The Global Hemoglobinopathy Market is estimated to be valued at US$ 636.9 Mn in 2025 and is expected to exhibit a CAGR of 5.9% over the forecast period 2025 to 2032. https://www.coherentmarketinsights.com/market-insight/hemoglobinopathy-treatment-market-2801